Akso Health Group ADR (AHG)vsCencora Inc. (COR)
AHG
Akso Health Group ADR
$0.75
-1.32%
HEALTHCARE · Cap: $634.05M
COR
Cencora Inc.
$309.87
-0.95%
HEALTHCARE · Cap: $59.59B
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 2405725% more annual revenue ($332.77B vs $13.83M). COR leads profitability with a 0.8% profit margin vs -135.0%. COR earns a higher WallStSmart Score of 62/100 (C+).
AHG
Avoid15
out of 100
Grade: F
COR
Buy62
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+10.2%
Fair Value
$1.57
Current Price
$0.75
$0.82 discount
Margin of Safety
-63.9%
Fair Value
$189.03
Current Price
$309.87
$120.84 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Every $100 of equity generates 86 in profit
Safe zone — low bankruptcy risk
Large-cap with strong market position
Growing faster than its price suggests
Generating 2.4B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -89.4% — below average capital efficiency
Revenue declined 12.9%
Trading at 19.4x book value
0.8% margin — thin
Operating margin of 1.4%
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Debt/Equity, Altman Z-Score.
Bull Case : COR
The strongest argument for COR centers on Return on Equity, Altman Z-Score, Market Cap. PEG of 0.66 suggests the stock is reasonably priced for its growth.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Return on Equity.
Bear Case : COR
The primary concerns for COR are Price/Book, Profit Margin, Operating Margin. Debt-to-equity of 3.84 is elevated, increasing financial risk. Thin 0.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
AHG profiles as a turnaround stock while COR is a value play — different risk/reward profiles.
COR carries more volatility with a beta of 0.57 — expect wider price swings.
COR is growing revenue faster at 5.1% — sustainability is the question.
COR generates stronger free cash flow (2.4B), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 15/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, dedicated to providing innovative medical solutions and comprehensive patient care services. With a strong emphasis on advanced health technologies, the company is strategically positioned in the telehealth and personalized medicine markets, supported by a robust research and development framework. As it navigates the rapidly evolving healthcare landscape, Akso Health Group presents an attractive investment opportunity for institutional investors seeking to capitalize on transformative trends within the industry.
Visit Website →Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?